Alberto Papi
- The Spectrum of Bronchial Infection
Edited by Francesco Blasi and Marc MiravitllesBook | Published in 2013DOI: 10.1183/1025448x.erm6013ISBN (electronic): 978-1-84984-035-4 - Impact of therapy reviews in real-world asthmaBy David Price, John Haughney, Dermot Ryan, Iain Small, Kevin Gruffydd-Jones, Alison Chisholm, Stanley Musgrave, Naheem Munir, Federico Lavorini and Alberto PapiDavid PriceJohn Haughney1Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United KingdomDermot RyanIain Small5General Practice with Specialist Interest in Respiratory Medicine, Peterhead Health Centre Forrest Road, Peterhead, United KingdomKevin Gruffydd-JonesAlison Chisholm2Observational Research, Research in Real Life, Norwich, United KingdomStanley Musgrave2Observational Research, Research in Real Life, Norwich, United KingdomNaheem Munir2Observational Research, Research in Real Life, Norwich, United KingdomFederico Lavorini8Department Internal Medicine, Section Respiratory Medicine, University of Florence, Florence, ItalyAlberto Papi9Research Centre on Asthma and COPD, University of Ferrara, Ferrara, Italy
- Rhinovirus infection upregulates pentraxin-3 in smokers and COPD patientsBy Joseph Footitt, Patrick Mallia, Sotero Rosa, Maria-Belen Trujillo-Torralbo, Tatiana Kebadze, Marco Contoli, Alberto Papi, Onn Min Kon, Rosario Maselli and Sebastian JohnstonJoseph Footitt1Respiratory Medicine, Imperial College, London, United KingdomPatrick MalliaSotero RosaMaria-Belen Trujillo-TorralboTatiana Kebadze1Respiratory Medicine, Imperial College, London, United KingdomMarco Contoli3Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyAlberto Papi3Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyOnn Min KonRosario Maselli4Dipartimento di Medicina Sperimentale e Clinica- Divisione Malattie Repiratorie, Universita' Degli Studi “Magna Graecia”, Catanzaro, Italy
- Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glandsBy Gaetano Caramori, Paolo Casolari, Elvira Garofano, Marco Contoli, Giulia Gnesini, Anna Padovani, Kian Fan Chung, Peter J. Barnes, Ian M. Adcock and Alberto PapiGaetano Caramori1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyPaolo Casolari1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyElvira Garofano1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyMarco Contoli1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyGiulia Gnesini1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyAnna Padovani1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyKian Fan Chung2Airways Disease Section, NHLI, Imperial College London, London, United KingdomPeter J. Barnes2Airways Disease Section, NHLI, Imperial College London, London, United KingdomIan M. Adcock2Airways Disease Section, NHLI, Imperial College London, London, United KingdomAlberto Papi1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, Italy
- Novel narrow spectrum kinase inhibitors inhibit rhinovirus replication via enhancement of interferon expression in nasal epithelial cells of atopic and non-atopic patientsBy Marco Contoli, Kazuhiro Ito, Donatella Poletti, Antonio Pastore and Alberto PapiMarco Contoli1Asthma and COPD Centre, Ferrara University, Ferrara, ItalyKazuhiro Ito2Biology, RespiVert Ltd, London, United KingdomDonatella Poletti3Ear, Throat and Nose Clinic, Ferrara University, Ferrara, ItalyAntonio Pastore3Ear, Throat and Nose Clinic, Ferrara University, Ferrara, ItalyAlberto Papi1Asthma and COPD Centre, Ferrara University, Ferrara, Italy
- Induction of cathelicidin (LL-37) in rhinovirus-induced COPD exacerbationsBy Rosa Sotero, Patrick Mallia, Joseph Footitt, Maria-Belen Trujillo-Torralbo, Tatiana Kebadze, Contoli Marco, Alberto Papi, Girolamo Pelaia, Rosario Maselli and Sebastian JohnstonRosa SoteroPatrick Mallia1Respiratory Medicine, Imperial College, London, United KingdomJoseph Footitt1Respiratory Medicine, Imperial College, London, United KingdomMaria-Belen Trujillo-Torralbo1Respiratory Medicine, Imperial College, London, United KingdomTatiana Kebadze1Respiratory Medicine, Imperial College, London, United KingdomContoli Marco3Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyAlberto Papi3Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyGirolamo Pelaia2Dipartimento di Medicina Sperimentale e Clinica-Sezione Di Malattie Respiratorie, Universita' Degli Studi “Magna Graecia”, Catanzaro, ItalyRosario Maselli2Dipartimento di Medicina Sperimentale e Clinica-Sezione Di Malattie Respiratorie, Universita' Degli Studi “Magna Graecia”, Catanzaro, ItalySebastian Johnston1Respiratory Medicine, Imperial College, London, United Kingdom
- Asthma control and lung function after step down from high dose ICS/LABA combination therapyBy Pierluigi Paggiaro, Gabriele Nicolini, Nunzio Crimi, Leonardo Maria Fabbri, Dario Olivieri, Andrea Rossi and Alberto PapiPierluigi Paggiaro1Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyGabriele Nicolini2Medical Affairs, Chiesi Farmaceutici, Parma, ItalyNunzio Crimi3Department of Internal and Specialistic Medicine, Section of Respiratory Diseases, University of Catania, Catania, ItalyLeonardo Maria Fabbri4Section of Respiratory Diseases, University of Modena, Modena, ItalyDario Olivieri5Department of Clinical Sciences, University of Parma, Parma, ItalyAndrea Rossi6Department of Pneumology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, ItalyAlberto Papi7Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy
- Up-regulation of decoy receptor D6 in COPDBy Erica Bazzan, Graziella Turato, Simonetta Baraldo, Andrea Ballarin, Fiorella Calabrese, Elisabetta Balestro, Benedetta Savino, Cinzia Cancellieri, Raffaella Bonecchi, Massimo Locati, Alberto Papi, Manuel Cosìo, Alberto Mantovani and Marina SaettaErica Bazzan1Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, ItalyGraziella Turato1Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, ItalySimonetta Baraldo1Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, ItalyAndrea Ballarin1Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, ItalyFiorella Calabrese2Department of Medical Diagnostic Sciences and Special Therapies, University of Padova, Padova, ItalyElisabetta Balestro1Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, ItalyBenedetta Savino3Department of Immunology and Inflammation, IRCCS Humanitas Clinical Institute, Rozzano-Milan, ItalyCinzia Cancellieri3Department of Immunology and Inflammation, IRCCS Humanitas Clinical Institute, Rozzano-Milan, ItalyRaffaella Bonecchi3Department of Immunology and Inflammation, IRCCS Humanitas Clinical Institute, Rozzano-Milan, ItalyMassimo Locati3Department of Immunology and Inflammation, IRCCS Humanitas Clinical Institute, Rozzano-Milan, ItalyAlberto Papi4Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyManuel Cosìo5Department of Medicine, McGill University, Montreal, CanadaAlberto Mantovani3Department of Immunology and Inflammation, IRCCS Humanitas Clinical Institute, Rozzano-Milan, ItalyMarina Saetta1Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy
- Fluticasone propionate/formoterol fumarate combination therapy is equally effective and well-tolerated when administered with or without a spacer device to patients with asthmaBy David Price, Alberto Papi, Kirsten Kaiser, Brigit Grothe and Mark LomaxDavid Price1Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United KingdomAlberto Papi2Research Centre on Asthma and COPD, Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyKirsten Kaiser3Clinical and Regulatory Development, SkyePharma AG, Muttenz, SwitzerlandBrigit Grothe4European Medical Science, Mundipharma Research Ltd., Cambridge, United KingdomMark Lomax4European Medical Science, Mundipharma Research Ltd., Cambridge, United Kingdom
- IL-33 has a nuclear distribution and is not increased in peripheral lung of COPD patientsBy Gaetano Caramori, Paolo Casolari, Anna Padovani, Elvira Garofano, Marco Contoli, Kian Fan Chung, Ian M. Adcock and Alberto PapiGaetano Caramori1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyPaolo Casolari1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyAnna Padovani1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyElvira Garofano1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyMarco Contoli1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyKian Fan Chung2Airways Disease Section, NHLI, Imperial College London, London, United KingdomIan M. Adcock2Airways Disease Section, NHLI, Imperial College London, London, United KingdomAlberto Papi1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, Italy
- Immunoregulation and FoxP3 expression in the bronchial mucosa of stable COPD patientsBy Antonino Di Stefano, Gaetano Caramori, Chiara Vicari, Isabella Gnemmi, Davide Vallese, Paola Brun, Andrea Zanini, Francesco Cappello, Fabio Ricciardolo, Alberto Papi and Bruno BalbiAntonino Di Stefano1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyGaetano Caramori1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyChiara Vicari1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyIsabella Gnemmi1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyDavide Vallese1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyPaola Brun1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyAndrea Zanini1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyFrancesco Cappello1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyFabio Ricciardolo1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyAlberto Papi1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, ItalyBruno Balbi1Citoimmunopatologia Cardio Respiratoria, Fondazione S. Maugeri, IRCCS, Veruno, Italy
- The utility of echocardiography in elderly smokers with COPD and of spirometry in elderly smokers with CHFBy Alessia Verduri, Bianca Beghé, Barbara Bottazzi, Alessandro Fucili, Alberto Papi, Licia Ballerin, Mariarita Stendardo, Alberto Mantovani, Claudio Ceconi, Leonardo M. Fabbri and Piera BoschettoAlessia Verduri1Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyBianca Beghé1Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyBarbara Bottazzi2Research Laboratory Immunology & Inflammation, Humanitas Clinical and Research Center, Rozzano, Milano, ItalyAlessandro Fucili3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyAlberto Papi3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyLicia Ballerin4Respiratory Physio-Pathology Unit, Hospital-University of Ferrara, Ferrara, ItalyMariarita Stendardo3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyAlberto Mantovani2Research Laboratory Immunology & Inflammation, Humanitas Clinical and Research Center, Rozzano, Milano, Italy5Department of Translational Medicine, University of Milan, Milano, ItalyClaudio Ceconi3Department of Medical Sciences, University of Ferrara, Ferrara, ItalyLeonardo M. Fabbri1Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyPiera Boschetto3Department of Medical Sciences, University of Ferrara, Ferrara, Italy
- Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPDBy Antonino Di Stefano, Gaetano Caramori, Adam Barczyk, Chiara Vicari, Paola Brun, Andrea Zanini, Francesco Cappello, Elvira Garofano, Anna Padovani, Marco Contoli, Andrew Durham, Peter Barnes, Kian Fan Chung, Alberto Papi, Ian Adcock and Bruno BalbiAntonino Di Stefano1Divisione Di Pneumologia e Citoimmunopatologia, Fondazione S. Maugeri, IRCCS, Veruno, Tradate, ItalyGaetano Caramori2Centro Interdipartimentale Per Lo Studio Delle Malattie Infiammatorie Delle Vie Aeree, Università Di Ferrara, Ferrara, ItalyAdam Barczyk3Katedra I Klinika Pneumologii, Universytetu Medycznego W Katowicach, Slaskiego, PolandChiara Vicari1Divisione Di Pneumologia e Citoimmunopatologia, Fondazione S. Maugeri, IRCCS, Veruno, Tradate, ItalyPaola Brun4Department of Biomedical Sciences, Università Di Padova, Padova, ItalyAndrea Zanini1Divisione Di Pneumologia e Citoimmunopatologia, Fondazione S. Maugeri, IRCCS, Veruno, Tradate, ItalyFrancesco Cappello5Dipartimento Di Biomedicina Sperimentale e Neuroscienze Cliniche, Università Di Palermo, Palermo, ItalyElvira Garofano2Centro Interdipartimentale Per Lo Studio Delle Malattie Infiammatorie Delle Vie Aeree, Università Di Ferrara, Ferrara, ItalyAnna Padovani2Centro Interdipartimentale Per Lo Studio Delle Malattie Infiammatorie Delle Vie Aeree, Università Di Ferrara, Ferrara, ItalyMarco Contoli2Centro Interdipartimentale Per Lo Studio Delle Malattie Infiammatorie Delle Vie Aeree, Università Di Ferrara, Ferrara, ItalyAndrew Durham6Airway Disease Section, National Heart and Lung Institute, London, United KingdomPeter Barnes6Airway Disease Section, National Heart and Lung Institute, London, United KingdomKian Fan Chung6Airway Disease Section, National Heart and Lung Institute, London, United KingdomAlberto Papi2Centro Interdipartimentale Per Lo Studio Delle Malattie Infiammatorie Delle Vie Aeree, Università Di Ferrara, Ferrara, ItalyIan Adcock6Airway Disease Section, National Heart and Lung Institute, London, United KingdomBruno Balbi1Divisione Di Pneumologia e Citoimmunopatologia, Fondazione S. Maugeri, IRCCS, Veruno, Tradate, Italy
- Fluticasone propionate/formoterol fumarate improves asthma control and reduces exacerbations compared with fluticasoneBy Alberto Papi, David Price, Joaquin Sastre, Kirsten Kaiser, Mark Lomax, Tammy McIver and Sanjeeva DissanayakeAlberto Papi1Research Centre on Asthma and COPD, University of Ferrara, Ferrara, ItalyDavid Price2Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United KingdomJoaquin Sastre3Department of Allergy, Fundación Jiménez Díaz, Madrid, SpainKirsten Kaiser4Clinical and Regulatory Development, Skyepharma, Muttenz, SwitzerlandMark Lomax5Clinical Data Management and Statistics, Mundipharma Research Limited, Cambridge, United KingdomTammy McIver5Clinical Data Management and Statistics, Mundipharma Research Limited, Cambridge, United KingdomSanjeeva Dissanayake6Medical Science - Respiratory, Mundipharma Research Limited, Cambridge, United Kingdom
- INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPDBy Andrea Rossi, Thys van der Molen, Ricardo del Olmo, Alberto Papi, Luis Wehbe, Matthew Quinn, Chengxing Lu, David Young, Ray Cameron, Enrica Bucchioni and Pablo AltmanArticle | Published in 2014 in European Respiratory JournalAndrea Rossi1Pulmonary Unit, University of Verona, Verona, ItalyThys van der Molen2University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsRicardo del Olmo3Fundación CIDEA and Hospital Maria Ferrer, Buenos Aires, ArgentinaAlberto Papi4University of Ferrara, Ferrara, ItalyLuis Wehbe5Fundacion Enfisema, Buenos Aires, ArgentinaMatthew Quinn6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAChengxing Lu6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USADavid Young7Novartis Horsham Research Centre, Horsham, UKRay Cameron7Novartis Horsham Research Centre, Horsham, UKEnrica Bucchioni8Novartis Farma, Origgio, ItalyPablo Altman6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
- INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPDBy Andrea Rossi, Thys van der Molen, Ricardo del Olmo, Alberto Papi, Luis Wehbe, Matthew Quinn, Chengxing Lu, David Young, Ray Cameron, Enrica Bucchioni and Pablo AltmanAndrea Rossi1Pulmonary Unit, University of Verona, Verona, ItalyThys van der Molen2University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsRicardo del Olmo3Fundación CIDEA and Hospital Maria Ferrer, Buenos Aires, ArgentinaAlberto Papi4University of Ferrara, Ferrara, ItalyLuis Wehbe5Fundacion Enfisema, Buenos Aires, ArgentinaMatthew Quinn6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAChengxing Lu6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USADavid Young7Novartis Horsham Research Centre, Horsham, UKRay Cameron7Novartis Horsham Research Centre, Horsham, UKEnrica Bucchioni8Novartis Farma, Origgio, ItalyPablo Altman6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
- Blood eosinophilia and the number of exacerbations in COPD patientsBy David Price, Anna Rigazio, Dirkje Postma, Alberto Papi, Bruselle Guy, Alvar Agusti, Antonio Anzueto, Claus Vogelmeier, Dermot Ryan, Daryl Freeman, Mike Thomas, Ian Pavord, Mona Bafadhel, Nicolas Roche, Rupert Jones, Ted Popov, Emilio Pizzichini, Alison Chisholm and Marjan KerkhofDavid Price1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom2Center of Academic Primary Care, University of Aberdeen, Aberdeen, United KingdomAnna Rigazio3Research in Real Life Ltd, (RiRL), Cambridge, United KingdomDirkje Postma1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom4Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsAlberto Papi1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom5Respiratory Medicine and Research Center on Asthma and COPD, University of Ferrara, Ferrara, ItalyBruselle Guy1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom6Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumAlvar Agusti1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom7Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, SpainAntonio Anzueto1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom8Pulmonary/Critical Care, University of Texas Health Science Center, San Antonio,Claus Vogelmeier1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom9Pulmonary Division, Marburg University Hospital, Marburg, GermanyDermot Ryan1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom10General Practice, Woodbrook Medical Centre, Loughborough, United KingdomDaryl Freeman1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom11General Practice, Mundesley Medical Centre, Norfolk, United KingdomMike Thomas1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom12Department of Primary Care Research, University of Southampton, Southampton, United KingdomIan Pavord1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom13Department of Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomMona Bafadhel1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom13Department of Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomNicolas Roche1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom14Department of Respiratory and Intensive Care Medicine, Hôtel-Dieu Hospital by University Paris, Paris, FranceRupert Jones1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom15Peninsula School of Medicine and Dentistry, Plymouth University, Plymouth, United KingdomTed Popov1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom16Clinic of Allergy & Asthma, Medical University Sofia, Sofia, BulgariaEmilio Pizzichini1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom17Department of Pulmonology, University of Santa Catarin, Florianópolis, BrazilAlison Chisholm1Respiratory Effectiveness Group, (REG), Cambridge, United KingdomMarjan Kerkhof3Research in Real Life Ltd, (RiRL), Cambridge, United Kingdom
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlvar AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authors
- Unmet needs for the assessment of small airways dysfunction in asthma: introduction to the ATLANTIS studyBy Dirkje S. Postma, Chris Brightling, Leo Fabbri, Thys van der Molen, Gabriele Nicolini, Alberto Papi, Klaus F. Rabe, Salman Siddiqui, Dave Singh, Maarten van den Berge and Monica KraftDirkje S. Postma1University of Groningen, University Medical Center Groningen, Dept of Pulmonology, Groningen, The NetherlandsChris Brightling2Dept of Infection, Immunity and Inflammation, Institute for Lung Health, University of Leicester, Leicester, UKLeo Fabbri3Dept of Oncology Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyThys van der Molen4University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsGabriele Nicolini5Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyAlberto Papi6Dept of Respiratory Medicine, University of Ferrara, Ferrara, ItalyKlaus F. Rabe7Dept of Medicine, Christian Albrechts University Kiel, Kiel and LungenClinic Grosshansdorf, Grosshansdorf, Germany (Members of the German Center for Lung Research (DZL))Salman Siddiqui8Dept of Infection, Immunity and Inflammation, Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, UKDave Singh9Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester, Manchester, UKMaarten van den Berge1University of Groningen, University Medical Center Groningen, Dept of Pulmonology, Groningen, The NetherlandsMonica Kraft10Dept of Medicine, University of Arizona Health Sciences Center, Tucson, AZ, USA
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar A. Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlvar A. AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section
- Biomarkers of oxidative-stress and inflammation in exhaled breath of hospital cleanersBy Enrico Casimirri, Mariarita Stendardo, Melissa Bonci, Roberta Andreoli, Barbara Bottazzi, Roberto Leone, Mischela Schito, Alberto Papi, Marco Contoli, Massimo Corradi and Piera BoschettoEnrico Casimirri1Medical Sciences, University of Ferrara, Ferrara, ItalyMariarita Stendardo1Medical Sciences, University of Ferrara, Ferrara, ItalyMelissa Bonci1Medical Sciences, University of Ferrara, Ferrara, ItalyRoberta Andreoli2Clinical and Experimental Medicine, University of Parma, Parma, ItalyBarbara Bottazzi3Istituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas, Rozzano, ItalyRoberto Leone3Istituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas, Rozzano, ItalyMischela Schito1Medical Sciences, University of Ferrara, Ferrara, ItalyAlberto Papi1Medical Sciences, University of Ferrara, Ferrara, ItalyMarco Contoli1Medical Sciences, University of Ferrara, Ferrara, ItalyMassimo Corradi2Clinical and Experimental Medicine, University of Parma, Parma, ItalyPiera Boschetto1Medical Sciences, University of Ferrara, Ferrara, Italy
- Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbationsBy Mike Thomas, David Price, John Blakey, Lynn Josephs, Ian Pavord, Borislav Dimitrov, Dirkje Postma, Alberto Papi, Alexandra Dima, Todor Popov, Hilary Pinnock, Iain Small, Alan Kaplan, Cynthia Rand, Janet Holbrook, Emilio Pizzichini, Gene Colice, Sam Walker, Annie Burden and Vasilis NikolaouMike Thomas1Primary Medical Care, University of Southampton, Southampton, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomDavid Price2Research in Real Life, RiRL, Singapore, Singapore18Research in Real Life, RiRL, Cambridge, United Kingdom19Centre for Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomJohn Blakey3Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomLynn Josephs1Primary Medical Care, University of Southampton, Southampton, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomIan Pavord4Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomBorislav Dimitrov5Faculty of Medicine, University of Southampton, Southampton, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomDirkje Postma6University of Groningen, University Medical Center Groningen, Groningen, Netherlands20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAlberto Papi7Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAlexandra Dima8Communication Science, University of Amsterdam, Amsterdam, Netherlands20Respiratory Effectiveness Group, REG, Cambridge, United KingdomTodor Popov9Clinic of Allergy & Asthma, Medical University Sofia, Sofia, Bulgaria20Respiratory Effectiveness Group, REG, Cambridge, United KingdomHilary Pinnock10Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomIain Small11Peterhead Medical Practice, Health Centre, Peterhead, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAlan Kaplan12Family and Community Medicine, University of Toronto, Toronto, Canada20Respiratory Effectiveness Group, REG, Cambridge, United KingdomCynthia Rand13Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, United States20Respiratory Effectiveness Group, REG, Cambridge, United KingdomJanet Holbrook14Epidemiology, Johns Hopkins University, Baltimore, United States20Respiratory Effectiveness Group, REG, Cambridge, United KingdomEmilio Pizzichini15Clinical Medicine, Federal University of Santa Catarina, Florianopolis, Brazil20Respiratory Effectiveness Group, REG, Cambridge, United KingdomGene Colice16School of Medicine, George Washington University, Washington DC, United States20Respiratory Effectiveness Group, REG, Cambridge, United KingdomSam Walker17Research and Policy, Asthma UK, London, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAnnie Burden18Research in Real Life, RiRL, Cambridge, United KingdomVasilis Nikolaou18Research in Real Life, RiRL, Cambridge, United Kingdom
- LATE-BREAKING ABSTRACT: Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD patientsBy Marco Contoli, Alessia Pauletti, Paolo Casolari, Giulia Gnesini, Maria Sandra Magnoni, Giacomo Curradi, Giacomo Forini, Brunilda Marku and Alberto PapiMarco Contoli1Respiratory Diseases, University of Ferrara, Ferrara, ItalyAlessia Pauletti1Respiratory Diseases, University of Ferrara, Ferrara, ItalyPaolo Casolari1Respiratory Diseases, University of Ferrara, Ferrara, ItalyGiulia Gnesini1Respiratory Diseases, University of Ferrara, Ferrara, ItalyMaria Sandra Magnoni2Medical and Scientific Department, GlaxoSmithKline Spa – Pharmaceuticals, Verona, ItalyGiacomo Curradi2Medical and Scientific Department, GlaxoSmithKline Spa – Pharmaceuticals, Verona, ItalyGiacomo Forini1Respiratory Diseases, University of Ferrara, Ferrara, ItalyBrunilda Marku1Respiratory Diseases, University of Ferrara, Ferrara, ItalyAlberto Papi1Respiratory Diseases, University of Ferrara, Ferrara, Italy
- INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms resultsBy Andrea Rossi, Thys Van der Molen, Ricardo Del Olmo, Alberto Papi, Luis Wehbe, Matthew Quinn, Chengxing Lu, David Young, Ray Cameron and Pablo AltmanAndrea Rossi1CardioThoracic Dept, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyThys Van der Molen2University Medical Center Groningen, University of Groningen, Groningen, NetherlandsRicardo Del Olmo3Fundación CIDEA, Hospital Maria Ferrer, Buenos Aires, ArgentinaAlberto Papi4Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, ItalyLuis Wehbe5Fundacion Enfisema, Carlos M. Alvear 3345, Buenos Aires, ArgentinaMatthew Quinn6Novartis Pharmaceuticals Corporation, East Hanover, NJ, United StatesChengxing Lu6Novartis Pharmaceuticals Corporation, East Hanover, NJ, United StatesDavid Young7Novartis Horsham Research Centre, Horsham, West Sussex, United KingdomRay Cameron7Novartis Horsham Research Centre, Horsham, West Sussex, United KingdomPablo Altman6Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
- Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthmaBy Richard Beasley, Ian Pavord, Alberto Papi, Helen K. Reddel, Tim Harrison, Guy B. Marks, Robert J. Hancox and Mark WeatherallArticle | Published in 2016 in European Respiratory JournalRichard Beasley1Medical Research Institute of New Zealand, Wellington, New ZealandIan Pavord2University of Oxford, Oxford, UKAlberto Papi3University of Ferrara, Ferrara, ItalyHelen K. Reddel4Woolcock Institute of Medical Research, University of Sydney, Sydney, AustraliaTim Harrison5Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, UKGuy B. Marks6University of New South Wales, Sydney, AustraliaRobert J. Hancox7Waikato Hospital, Hamilton, New Zealand8University of Otago, Dunedin, New ZealandMark Weatherall9University of Otago Wellington, Wellington, New Zealand
- Assessing small airway impairment in mild-to-moderate smoking asthmatic patientsBy Marco Contoli, Federico Bellini, Luca Morandi, Giacomo Forini, Stefano Bianchi, Giulia Gnesini, Brunilda Marku, Klaus F. Rabe and Alberto PapiArticle | Published in 2016 in European Respiratory JournalMarco Contoli1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyFederico Bellini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyLuca Morandi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyGiacomo Forini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyStefano Bianchi2Dept of Pharmacy, University Hospital of Ferrara, Ferrara, ItalyGiulia Gnesini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyBrunilda Marku1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyKlaus F. Rabe3LungClinic Grosshansdorf, Member of the German Center for Lung Research, Grosshansdorf, Germany4Dept of Medicine, Christian Albrechts University Kiel, Member of the German Center for Lung Research, Kiel, GermanyAlberto Papi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthmaBy Richard Beasley, Ian Pavord, Alberto Papi, Helen K. Reddel, Tim Harrison, Guy B. Marks, Robert J. Hancox and Mark WeatherallRichard Beasley1Medical Research Institute of New Zealand, Wellington, New ZealandIan Pavord2University of Oxford, Oxford, UKAlberto Papi3University of Ferrara, Ferrara, ItalyHelen K. Reddel4Woolcock Institute of Medical Research, University of Sydney, Sydney, AustraliaTim Harrison5Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, UKGuy B. Marks6University of New South Wales, Sydney, AustraliaRobert J. Hancox7Waikato Hospital, Hamilton, New Zealand8University of Otago, Dunedin, New ZealandMark Weatherall9University of Otago Wellington, Wellington, New Zealand
- Assessing small airway impairment in mild-to-moderate smoking asthmatic patientsBy Marco Contoli, Federico Bellini, Luca Morandi, Giacomo Forini, Stefano Bianchi, Giulia Gnesini, Brunilda Marku, Klaus F. Rabe and Alberto PapiMarco Contoli1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyFederico Bellini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyLuca Morandi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyGiacomo Forini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyStefano Bianchi2Dept of Pharmacy, University Hospital of Ferrara, Ferrara, ItalyGiulia Gnesini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyBrunilda Marku1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyKlaus F. Rabe3LungClinic Grosshansdorf, Member of the German Center for Lung Research, Grosshansdorf, Germany4Dept of Medicine, Christian Albrechts University Kiel, Member of the German Center for Lung Research, Kiel, GermanyAlberto Papi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- Acute Exacerbations of Pulmonary Diseases
Edited by Pierre-Régis Burgel, Marco Contoli and José Luis López-CamposBook | Published in 2017DOI: 10.1183/2312508X.erm7717ISBN (electronic): 978-1-84984-090-3Pierre-Régis BurgelMarco Contoli
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
